← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3320)
- Plasma metabolomics for the assessment of the progression of non-small cell lung cancer. (2023/03/01) ♡
- Rural-Urban Disparities in Receipt of Surgery for Potentially Resectable Non-Small Cell Lung Cancer. (2023/03/01) ♡
- Wedge Resection Versus Segmentectomy for Older Patients With Stage IA Non-Small-Cell Lung Cancer. (2023/03/01) ♡
- Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer. (2023/03/01) ♡
- Identification of phytochemical compounds of Fagopyrum dibotrys and their targets by metabolomics, network pharmacology and molecular docking studies. (2023/03/01) ♡
- CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-dependent signaling pathway. (2023/02/27) ♡
- Profile of Lung Cancer in two Niger Delta States of Nigeria: An Evaluation of 43 Cases. (2023/02/24) ♡
- Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer. (2023/02/20) ♡
- Reverse predictive analysis of Rhizoma Pinelliae and Rhizoma Coptidis on differential miRNA target genes in lung adenocarcinoma. (2023/02/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive overview of the relationship between RET gene and tumor occurrence. (2023/02/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chinese patent medicine Kanglaite injection for non-small-cell lung cancer: An overview of systematic reviews. (2023/02/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro antioxidant, anti-inflammatory, and anticancer activities of mixture Thai medicinal plants. (2023/02/10) ♡
- Unraveling the Role of Scutellaria baicalensis for the Treatment of Breast Cancer Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. (2023/02/10) ♡
- Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer. (2023/02/09) ♡
- Safety and efficacy of stereotactic ablative brachytherapy as a salvage therapy for recurrent chest wall cancer: A retrospective, multicenter study. (2023/02/07) ♡
- Macamide B suppresses lung cancer progression potentially via the ATM signaling pathway. (2023/02/06) ♡
- Docosahexaenoic acid reverses PD-L1-mediated immune suppression by accelerating its ubiquitin-proteasome degradation. (2023/02/01) ♡
- CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy. (2023/02/01) ♡
- Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD-1 inhibitor therapy. (2023/02/01) ♡
- GLIM diagnosed malnutrition predicts clinical outcomes and quality of life in patients with non-small cell lung cancer. (2023/02/01) ♡
- Prognostic evaluation of preoperative serum tumor marker negative cases in non-small cell lung cancer: A retrospective study. (2023/02/01) ♡
- Systematic study of tissue factor expression in solid tumors. (2023/02/01) ♡
- Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer. (2023/01/31) ♡
- Hybrid uniportal robotic-assisted thoracoscopic surgery using video-assisted thoracoscopic surgery staplers: technical aspects and results. (2023/01/31) ♡
- Treatment patterns and outcomes in patients with Pancoast tumors: a national cancer database analysis. (2023/01/31) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Surgical evaluation of station 4L in patients with lung cancer: the Ugly Duckling. (2023/01/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Palliative extracranial radiotherapy in patients receiving immunotherapy for non-small cell lung cancer: a narrative review. (2023/01/30) ♡
- Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer. (2023/01/27) ♡
- Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments. (2023/01/27) ♡
- What is the appropriate “first lymph node” in the era of segmentectomy for non-small cell lung cancer? (2023/01/26) ♡
- Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients. (2023/01/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis. (2023/01/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers. (2023/01/24) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Brain and leptomeningeal metastases in lung cancer. (2023/01/23) ♡
- Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients. (2023/01/23) ♡
- The Effect of Citrus aurantium on Non-Small-Cell Lung Cancer: A Research Based on Network and Experimental Pharmacology. (2023/01/23) ♡
- An ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry method based on a four-step analysis strategy to investigate metabolites of Qi-Yu-San-Long decoction in rat plasma. (2023/01/15) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Platelet lymphocyte ratio is a prognostic marker in small cell lung cancer-A systemic review and meta-analysis. (2023/01/13) ♡
- Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy. (2023/01/13) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models. (2023/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Surgery of Old People-Thoracic Surgery]. (2023/01/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Precision oncology provides opportunities for targeting KRAS-inhibitor resistance. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sarcoid-Like Granulomatosis of the Lung Related to Durvalumab After Chemoradiation for Pulmonary Squamous Cell Carcinoma. (2023/01/01) ♡
- Non-Lobe Specific Metastases in Occult N2 after Lobectomy for Clinical N0 Non-Small Cell Lung Cancer. (2023/01/01) ♡
- Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer. (2023/01/01) ♡
- A clinical nomogram based on absolute count of lymphocyte subsets for predicting overall survival in patients with non-small cell lung cancer. (2023/01/01) ♡
- Efficacy and Safety of East Asian Herbal Medicine for Brain Metastases in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis Protocol to Identify Specific Herbs. (2023/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.